The Effect of Vitamin D Supplements on Reducing the Size of Uterine Leiomyoma in Women with Vitamin D Deficiency

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Resident, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Regarding the high prevalence of uterine leiomyoma and vitamin D deficiency, this study aimed to determine the effect of administration of vitamin D supplement on the amount of uterine leiomyoma in women with vitamin D deficiency.Methods: In a double-blind clinical trial, 70 patients with uterine leiomyoma and vitamin D deficiency were distributed in two equal groups, which received supplements of 50,000 unit of vitamin D every two weeks for 10 weeks and placebo, respectively. Serum level of vitamin D and size of uterine leiomyoma was measured in both groups before and 10 weeks after treatment, and compared between the two groups.Findings: 10 weeks after the intervention, serum level of vitamin D was 36.08 ± 11.15 and 16.25 ± 5.52 ng/dl in case and control groups, respectively, and the difference between the two groups was significant (P < 0.001). Moreover, 10 weeks after the intervention, the mean size of leiomyoma was 52.58 ± 14.4 and 61.11 ± 12.5 mm in case and control groups, respectively, and the difference between the two groups was significant (P = 0.006).Conclusion: The findings suggest that vitamin D intake decreases the amount of uterine leiomyoma, and therefore it seems that vitamin D is a good way to treat leiomyoma.

Keywords

References

  1. Perez-Lopez FR, Ornat L, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, et al. EMAS position statement: Management of uterine fibroids. Maturitas 2014; 79(1): 106-16.
  2. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 2003; 111(8): 1037-54.
  3. Hillard PJA. Benign diseases of the female reproductive tract: Symptoms and signs. In: Berek JS, editor. Novaks gynecology. 13th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002. p. 351-420.
  4. Hoffman PJ, Milliken DB, Gregg LC, Davis RR, Gregg JP. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 2004; 82(3): 639-49.
  5. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: An ecologic meta-regression analysis. Osteoporos Int 2009; 20(1): 133-40.
  6. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79(3): 362-71.
  7. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80(6 Suppl): 1689S-96S.
  8. Wise LA, Palmer JR, Ruiz-Narvaez E, Reich DE, Rosenberg L. Is the observed association between dairy intake and fibroids in African Americans explained by genetic ancestry? Am J Epidemiol 2013; 178(7): 1114-9.
  9. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr 2011; 29(2): 149-55.
  10. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326(7387): 469.
  11. Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87(4): 1080S-6S.
  12. van der Meer IM, Karamali NS, Boeke AJ, Lips P, Middelkoop BJ, Verhoeven I, et al. High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 2006; 84(2): 350-3.
  13. Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin d and the risk of uterine fibroids. Epidemiology 2013; 24(3): 447-53.
  14. Halder SK, Sharan C, Al-Hendy O, Al-Hendy A. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reprod Sci 2014; 21(9): 1108-19.
  15. Blauer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril 2009; 91(5): 1919-25.
  16. Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod 2012; 86(4): 116.
  17. Al-Hendy A, Diamond MP, El-Sohemy A, Halder SK. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.
  18. J Clin Endocrinol Metab 2015; 100(4): E572-E582.
  19. Oskovi Kaplan ZA, Tasci Y, Topcu HO, Erkaya S. 25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma. Gynecol Endocrinol 2018; 34(3): 261-4.
  20. Ciavattini A, Delli CG, Serri M, Vignini A, Sabbatinelli J, Tozzi A, et al. Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation. Medicine (Baltimore) 2016; 95(52): e5698.
  21. Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK. Role of vitamin D in uterine fibroid biology. Fertil Steril 2015; 104(3): 698-706.
  22. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007; 87(4): 725-36.
Journal of Isfahan Medical School
Volume 36, Issue 501 - Serial Number 501
September and October 2017
Pages 1282-1287

Files

History

  • Receive Date: 10 August 2018
  • Revise Date: 26 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics